Symposium 2: Neurobiology of BDNF in Major Depression

Saturday, 28 February 2009 11:00 - 12:30, Plaza Room 1 & 2

Chair Maarten van den Buuse Mental Health Research Institute of VictoriaAustralia
BDNF and TrkB mRNA Reductions in the Frontal Cortex and Hippocampus in Major Mental Illness may be Reversed by Antidepressants
  • Prof Cyndi S Weickert, SRI, UNSW, POWMRI, Australia
Gene-environment interactions and exon-specific dysregulation of BDNF expression in a transgenic mouse model of depression-like behaviours
  • A/Prof Anthony J Hannan, Howard Florey Institute, Florey Neuroscience Institutes, University of Melbourne, Australia
Role of BDNF in behaviour: studies in rats and BDNF mutant mice
  • Maarten van den Buuse, Mental Health Research Institute of Victoria, Australia
Pathways of risk for depression: BDNFVal66Met, stress and emotional brain systems
  • Prof Leanne M Williams, Westmead Millennium Institute and University of Sydney, Australia
  • Dr Justine M Gatt, Westmead Millennium Institute and University of Sydney, Australia
  • Prof Peter R Schofield, Prince of Wales Medical Research Institute, Australia
  • Prof Charles Nemeroff, Emory University, United States
  • Dr Evian Gordon, Brain Resource; Westmead Millennium Institute and University of Sydney, Australia